Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins

Objective To investigate the combined effect of the apolipoprotein E 4 (ApoE'4) allele and midlife cardiovascular risk factors on cognitive decline. Methods Data are from the National Heart, Lung, and Blood Institute Twin Study-a longitudinal cardiovascular epidemiologic study of World War I1 male veteran twins currently in its 27th year of follow-up. Subjects were assessed for cardiovascular risk factors, including BP and glucose levels, at mean ages 48, 58, and 63 years. Participants in the current study are 410 individual twin subjects for whom cognitive function was measured twice, at ages 63 and 73 years. Ten-year change scores in performance on neuropsychological test examinations were adjusted for age, education, baseline score, and incident cardiovascular disease. Results For the sample as a whole, we observed a significant decline (p < 0.01) in cognitive performance over the 10 years of follow-up. ApoE'4 carriers with midlife hyperglycemia experienced the greatest decline in performance, which was also greater than expected from the separate effects combined. Midlife hypertension and ApoE'4, were each associated with excess decline in performance on tests of psychomotor speed. Their joint effect, however, was not greater than expected from the separate effects combined. Conclusions ApoE'4 and midlife cardiovascular risk factors may have a synergistic effect on decline in cognitive function. This effect may be due to greater vascular or degenerative damage among subjects with ApoE'4. NEUROLOGY 1998;50:1580–1585

[1]  P. Eslinger,et al.  Correlates of change in cognitive function in survivors from the Western Collaborative Group Study. , 1997, Neuroepidemiology.

[2]  A. Goate,et al.  Exploring the etiology of Alzheimer disease using molecular genetics. , 1997, JAMA.

[3]  E M Wijsman,et al.  Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease , 1995, Neurology.

[4]  E. Feskens,et al.  Apolipoprotein e4 allele and cognitive decline in elderly men , 1994, BMJ.

[5]  W. Strittmatter,et al.  ApoE genotype and survival from intracerebral haemorrhage , 1995, The Lancet.

[6]  E. Feskens,et al.  Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. , 1996, Stroke.

[7]  D. Carmelli,et al.  Concordance of ischemic heart disease in the NHLBI twin study after 14-18 years of follow-up. , 1991, Journal of clinical epidemiology.

[8]  M. Rossor,et al.  Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. , 1994, Human molecular genetics.

[9]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[10]  N. R. Schultz,et al.  A longitudinal study of neuropsychological performance by hypertensives and normotensives: a third measurement point. , 1989, Journal of gerontology.

[11]  D. Carmelli,et al.  Performance on the digit symbol substitution test and 5-year mortality in the Western Collaborative Group Study. , 1995, American journal of epidemiology.

[12]  G. Frisoni,et al.  Apolipoprotein E ε4 Allele in Alzheimer's Disease and Vascular Dementia , 1994 .

[13]  M. Laakso,et al.  Essential hypertension and cognitive function. The role of hyperinsulinemia. , 1993, Hypertension.

[14]  A. Hofman,et al.  Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.

[15]  J. Blass.  Pathophysiology of the Alzheimer's syndrome , 1993 .

[16]  J. Selby,et al.  Concordance for dyslipidemic hypertension in male twins. , 1991, JAMA.

[17]  E. Boerwinkle,et al.  The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. , 1991, American journal of human genetics.

[18]  R. Havlik,et al.  The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.

[19]  J. V. van Swieten,et al.  Hypertension in the elderly is associated with white matter lesions and cognitive decline , 1991, Annals of neurology.

[20]  S. Jablon,et al.  The NAS-NRC twin panel: methods of construction of the panel, zygosity diagnosis, and proposed use. , 1967, American journal of human genetics.

[21]  D. Carmelli,et al.  Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele. , 1994, Archives of neurology.

[22]  A. Mackinnon,et al.  Apolipoprotein E allele ∈4, dementia, and cognitive decline in a population sample , 1995, The Lancet.